MAPT and Brain atrophy: Although most patients with AD show tau-PET signal in the medial and inferior temporal cortex, regional patterns are highly variable across patients and tau-PET usually mirrors both the regional patterns of neurodegeneration (i.e., brain atrophy observed on MRI) and clinical symptoms.